These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 29324463)
1. Fractures Related to Tenofovir: A Case/Noncase Study in the European Pharmacovigilance Database. García MG; Larrinaga-Torrontegui U; Eduardo Martinez E; Lertxundi U; Palacios-Zabalza I; Aguirre C Am J Ther; 2019; 26(5):e589-e592. PubMed ID: 29324463 [TBL] [Abstract][Full Text] [Related]
2. Association of tenofovir disoproxil fumarate exposure with chronic kidney disease and osteoporotic fracture in US veterans with HIV. Sutton SS; Magagnoli J; Hardin JW; Hsu LI; Beaubrun A; Majethia S; Cummings TH Curr Med Res Opin; 2020 Oct; 36(10):1635-1642. PubMed ID: 32856940 [TBL] [Abstract][Full Text] [Related]
3. Glucagon-like peptide-1 analogues and thyroid cancer: An analysis of cases reported in the European pharmacovigilance database. Mali G; Ahuja V; Dubey K J Clin Pharm Ther; 2021 Feb; 46(1):99-105. PubMed ID: 32926446 [TBL] [Abstract][Full Text] [Related]
4. Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents. Bedimo R; Maalouf NM; Zhang S; Drechsler H; Tebas P AIDS; 2012 Apr; 26(7):825-31. PubMed ID: 22301411 [TBL] [Abstract][Full Text] [Related]
5. Osteoporosis-Related Fractures in HIV-Infected Patients Receiving Long-Term Tenofovir Disoproxil Fumarate: An Observational Cohort Study. Komatsu A; Ikeda A; Kikuchi A; Minami C; Tan M; Matsushita S Drug Saf; 2018 Sep; 41(9):843-848. PubMed ID: 29623648 [TBL] [Abstract][Full Text] [Related]
6. Renal and Bone Adverse Effects of a Tenofovir-Based Regimen in the Treatment of HIV-Infected Children: A Systematic Review. Okonkwo RI; Weidmann AE; Effa EE Drug Saf; 2016 Mar; 39(3):209-18. PubMed ID: 26692394 [TBL] [Abstract][Full Text] [Related]
7. Factors associated with fractures in HIV-infected persons: which factors matter? Gedmintas L; Wright EA; Dong Y; Lehmann E; Katz JN; Solomon DH; Losina E Osteoporos Int; 2017 Jan; 28(1):239-244. PubMed ID: 27421978 [TBL] [Abstract][Full Text] [Related]
8. Acetazolamide-induced pulmonary oedema: A disproportionality analysis from the EudraVigilance database. García M; Albizua Madariaga I; Sainz-Gil M; Lertxundi U Br J Clin Pharmacol; 2024 Jul; 90(7):1751-1755. PubMed ID: 38770584 [TBL] [Abstract][Full Text] [Related]
9. Tramadol-induced hiccups: a case-noncase study in the European pharmacovigilance database. García M; Lertxundi U; Aguirre C Ther Adv Drug Saf; 2021; 12():20420986211021230. PubMed ID: 34211690 [TBL] [Abstract][Full Text] [Related]
10. Impact of Antiretroviral Drugs on Fracture Risk in HIV-Infected Individuals: A Case-Control Study Nested Within the French Hospital Database on HIV (FHDH-ANRS CO4). Costagliola D; Potard V; Lang S; Abgrall S; Duvivier C; Fischer H; Joly V; Lacombe JM; Valantin MA; Mary-Krause M; Rozenberg S J Acquir Immune Defic Syndr; 2019 Feb; 80(2):214-223. PubMed ID: 30422911 [TBL] [Abstract][Full Text] [Related]
11. Differential skeletal impact of tenofovir disoproxil fumarate in young versus old HIV-infected adults. Grant PM; Kitch D; McComsey GA; Tierney C; Ha B; Brown TT HIV Clin Trials; 2015; 16(2):66-71. PubMed ID: 25872972 [TBL] [Abstract][Full Text] [Related]
12. Real-World Assessment of Renal and Bone Safety among Patients with HIV Infection Exposed to Tenofovir Disoproxil Fumarate-Containing Single-Tablet Regimens. Nkhoma ET; Rosenblatt L; Myers J; Villasis-Keever A; Coumbis J PLoS One; 2016; 11(12):e0166982. PubMed ID: 27941989 [TBL] [Abstract][Full Text] [Related]
13. Benefits of combining change-point analysis with disproportionality analysis in pharmacovigilance signal detection. Trinh NTH; Solé E; Benkebil M Pharmacoepidemiol Drug Saf; 2019 Mar; 28(3):370-376. PubMed ID: 29992679 [TBL] [Abstract][Full Text] [Related]
14. Prevalence and significance of proximal renal tubular abnormalities in HIV-infected patients receiving tenofovir. Casado JL; Bañón S; Santiuste C; Serna J; Guzman P; Tenorio M; Liaño F; del Rey JM AIDS; 2016 Jan; 30(2):231-9. PubMed ID: 26684820 [TBL] [Abstract][Full Text] [Related]
15. Spontaneous reports of vaccination errors in the European regulatory database EudraVigilance: A descriptive study. Hoeve CE; van Haren A; Sturkenboom MCJM; Straus SMJM Vaccine; 2018 Dec; 36(52):7956-7964. PubMed ID: 30416019 [TBL] [Abstract][Full Text] [Related]
16. Tenofovir and bone health. Grant PM; Cotter AG Curr Opin HIV AIDS; 2016 May; 11(3):326-32. PubMed ID: 26859637 [TBL] [Abstract][Full Text] [Related]
17. Incidence and risk factors for tenofovir-associated renal toxicity in HIV-infected patients. Quesada PR; Esteban LL; García JR; Sánchez RV; García TM; Alonso-Vega GG; Ferrández JS Int J Clin Pharm; 2015 Oct; 37(5):865-72. PubMed ID: 26008219 [TBL] [Abstract][Full Text] [Related]
18. SGLT-2 inhibitors and ketoacidosis: a disproportionality analysis in the World Health Organization's adverse drug reactions database. Ado Moumouni AN; Robin P; Hillaire-Buys D; Faillie JL Fundam Clin Pharmacol; 2018 Apr; 32(2):216-226. PubMed ID: 29144574 [TBL] [Abstract][Full Text] [Related]
19. Analysis of pharmacovigilance databases for spontaneous reports of adverse drug reactions related to substandard and falsified medical products: A descriptive study. Pozsgai K; Szűcs G; Kőnig-Péter A; Balázs O; Vajda P; Botz L; Vida RG Front Pharmacol; 2022; 13():964399. PubMed ID: 36147337 [No Abstract] [Full Text] [Related]
20. HIV Infection, Tenofovir, and Urine α1-Microglobulin: A Cross-sectional Analysis in the Multicenter AIDS Cohort Study. Jotwani V; Scherzer R; Estrella MM; Jacobson LP; Witt MD; Palella FJ; Macatangay B; Bennett M; Parikh CR; Ix JH; Shlipak MG Am J Kidney Dis; 2016 Oct; 68(4):571-581. PubMed ID: 27287300 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]